Business Context and Reporting Period
Company: Medifast, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2007
Business Overview: Medifast provides weight management products and programs through direct marketing, the "Take Shape for Life" network, doctors, and clinics. The company operates manufacturing and distribution facilities and is expanding its clinic division under the "Medifast Weight Control Center" brand.
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Revenue | $20,089,000 | $19,183,000 |
| Gross Profit | $15,031,000 | $14,405,000 |
| Gross Margin | 74.8% | 75.1% |
| Operating Income | $2,239,000 | $3,087,000 |
| Net Income | $1,422,000 | $1,694,000 |
| Diluted EPS | $0.10 | $0.13 |
| Cash from Operations | $1,720,000 | $3,402,000 |
| Cash and Equivalents (End of Period) | $1,857,000 | $3,793,000 |
| Total Debt (Current + Long-term) | $5,826,000 | $4,903,000* |
*Note: Q1 2006 debt figures are derived from the balance sheet comparison where Q1 2006 data is not explicitly totaled in the text, but Q4 2006 debt was $4,765,000. The Q1 2007 total debt is the sum of Line of Credit ($1,906,000), Current Maturities ($528,000), and Long-term Debt ($3,392,000).
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 5% ($906,000) year-over-year. Growth was driven by a 21% increase in the clinic division, a 6% increase in the "Take Shape for Life" network, and a 4% increase in direct response sales.
- Profitability Decline: Despite revenue growth, Net Income decreased 16% ($272,000) to $1.422 million. Operating income dropped 27% to $2.239 million.
- Expense Increases: Selling, General, and Administrative (SG&A) expenses rose 13% to $12.792 million. This was primarily due to a significant increase in stock compensation expense ($241,000 in 2007 vs. $33,000 in 2006) related to executive vesting and increased advertising spend ($4.3 million in Q1 2007).
- Cash Flow: Net cash provided by operating activities decreased significantly by 49% to $1.72 million, largely due to increases in inventory ($452,000) and prepaid expenses ($885,000).
- Liquidity: Cash on hand increased from $1.085 million at year-end 2006 to $1.857 million at March 31, 2007, supported by a $650,000 increase in the line of credit.
Outlook, Risks, and Management Commentary
- Strategic Focus: Management is investing heavily in executive expertise (new VP of Direct Response, EVP of Take Shape for Life, and CIO) and IT infrastructure to support high-tech business models. The company anticipates these hires will improve division effectiveness in the short and long term.
- Advertising Strategy: The company spent $4.3 million on direct response marketing in Q1 2007. The quarterly advertising budget is expected to increase in Q2 and Q3 2007 with new TV commercials, infomercials, and expanded web presence.
- Expansion: The clinic division is expanding with new locations in Florida and Texas in Q2 and Q3. Franchise opportunities for the clinic model are expected to be available by the end of Q2.
- Tax Outlook: The effective tax rate for Q1 2007 was 28%. Management anticipates a tax rate of approximately 36-38% for the full year 2007.
- Seasonality: Historically, the company experiences a "diet season" boost in January and February. In 2007, seasonality has not been a significant factor due to increased consumer awareness of health benefits.
- Risks: The filing contains standard forward-looking statement disclaimers regarding risks and uncertainties. No material pending litigation was reported as of March 31, 2007.
Investor Verification Checklist
- Stock Compensation Impact: Verify the sustainability of the $241,000 stock compensation expense increase and its effect on future earnings.
- Advertising ROI: Monitor the return on the increased $4.3 million advertising spend and the effectiveness of new campaigns launched in Q1.
- Clinic Expansion: Track the opening of new clinics in Florida and Texas and the rollout of franchise opportunities in Q2/Q3.
- Inventory Levels: Review the $452,000 increase in inventory to ensure it aligns with sales growth and does not indicate overstocking.
- Debt Utilization: Observe the utilization of the line of credit, which increased by $650,000 in the quarter.